Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paediatric treatment issues.

S Walters1

  • 1St Mary's Hospital Medical School, Imperial College, London, UK.

International Journal of Clinical Practice. Supplement
|January 6, 2000
PubMed
Summary
This summary is machine-generated.

New anti-human immunodeficiency virus (HIV) agents are needed for children. Efavirenz shows promise as a potent, once-daily treatment option with good central nervous system penetration and palatability for pediatric HIV therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"In My Community, if You're an Addict, People Don't Just Look Down on You for the Drugs, but for Being Black, Too": Black and Latine Methadone Patients' Experiences Around Addiction, Methadone Treatment, and Intersectional Stigma.

Journal of racial and ethnic health disparities·2026
Same author

Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC).

ESMO real world data and digital oncology·2026
Same author

The give and take of social support in professional athlete career pathways.

Journal of sports sciences·2026
Same author

Acute exertional compartment syndrome of the supraspinatus.

Annals of the Royal College of Surgeons of England·2025
Same author

Emerging athletes' career transitions in professional sport: an existential multi-case perspective.

Frontiers in sports and active living·2024
Same author

The accuracy of prehospital triage decisions in English trauma networks - a case-cohort study.

Scandinavian journal of trauma, resuscitation and emergency medicine·2024
Same journal

Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.

International journal of clinical practice. Supplement·2015
Same journal

Efficacy and safety of basiliximab in liver transplantation for patients with hepatitis B virus-related diseases: a single centre study.

International journal of clinical practice. Supplement·2015
Same journal

Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.

International journal of clinical practice. Supplement·2015
Same journal

Interleukin-2 receptor antagonist compared with antithymocyte globulin induction therapy in kidney transplantation from donors after cardiac death.

International journal of clinical practice. Supplement·2015
Same journal

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

International journal of clinical practice. Supplement·2015
Same journal

Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.

International journal of clinical practice. Supplement·2015
See all related articles

Area of Science:

  • Pediatric infectious diseases
  • Antiviral drug development
  • HIV/AIDS therapeutics

Background:

  • Limited therapeutic options for pediatric HIV infection compared to adults.
  • Need for novel anti-HIV agents to expand treatment choices for children.
  • Key considerations for pediatric HIV treatment include potency, CNS penetration, once-daily dosing, palatability, safety, and drug compatibility.

Purpose of the Study:

  • To evaluate the suitability of efavirenz for treating HIV infection in pediatric patients.
  • To highlight the properties of efavirenz that address the specific needs of pediatric HIV therapy.

Main Methods:

  • Review of existing therapeutic options for pediatric HIV.
  • Assessment of efavirenz's pharmacological and clinical properties in the context of pediatric treatment requirements.

Related Experiment Videos

  • Consideration of clinical evidence supporting efavirenz use in children.

    • Main Results:

    • Efavirenz possesses properties beneficial for pediatric HIV treatment, including potent antiviral activity.
    • Efavirenz offers once-daily dosing, potentially improving adherence.
    • Adequate central nervous system penetration and a favorable safety profile are noted.

    Conclusions:

    • Efavirenz demonstrates significant potential as a valuable therapeutic option for pediatric HIV infection.
    • Recent clinical evidence supports the efficacy and utility of efavirenz in pediatric patients.
    • Efavirenz may help broaden the range of effective treatments for children with HIV.